Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2012, Article ID 730923, 6 pages
http://dx.doi.org/10.1155/2012/730923
Clinical Study

Association between High-Sensitivity C-Reactive Protein and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Hepatitis C Virus Infection

1Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
2Heart Center, Peking University People’s Hospital, Beijing 100044, China

Received 17 January 2012; Accepted 21 February 2012

Academic Editor: Sunil Kumar Manna

Copyright © 2012 Wenliang Che et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Matsumori, “Hepatitis C virus infection and cardiomyopathies,” Circulation Research, vol. 96, no. 2, pp. 144–147, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi, “Chronic variant of myocarditis associated with hepatitis C virus infection,” Circulation, vol. 96, no. 1, pp. 22–24, 1997. View at Google Scholar · View at Scopus
  3. C. Vassalle, S. Masini, F. Bianchi, and G. C. Zucchelli, “Evidence for association between hepatitis C virus seropositivity and coronary artery disease,” Heart, vol. 90, no. 5, pp. 565–566, 2004. View at Google Scholar · View at Scopus
  4. W. Che, W. Liu, Y. Wei et al., “Increased serum N-terminal pro-B-type natriuretic peptide and left ventricle diastolic dysfunction in patients with hepatitis C virus infection,” Journal of Viral Hepatitis. In press. View at Publisher · View at Google Scholar
  5. T. A. Pearson, G. A. Mensah, R. W. Alexander et al., “Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association,” Circulation, vol. 107, no. 3, pp. 499–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Y. Yang, V. Nambi, Z. Tang et al., “Clinical Implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. Population. Insights From the ARIC (Atherosclerosis Risk in Communities) Study,” Journal of the American College of Cardiology, vol. 54, no. 25, pp. 2388–2395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Kaptoge et al., “C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis,” Lancet, vol. 375, no. 9709, pp. 132–140, 2010. View at Google Scholar
  8. P. M. Ridker, N. Rifai, L. Rose, J. E. Buring, and N. R. Cook, “Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events,” New England Journal of Medicine, vol. 347, no. 20, pp. 1557–1565, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Shima, K. Nakao, Y. Kato, K. Nakata, N. Ishii, and S. Nagataki, “Comparative study of C-reactive protein in chronic hepatitis B and chronic hepatitis C,” Tohoku Journal of Experimental Medicine, vol. 178, no. 3, pp. 287–297, 1996. View at Google Scholar · View at Scopus
  10. L. Kalabay, E. Nemesánszky, A. Csepregi et al., “Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-α2b,” International Immunology, vol. 16, no. 1, pp. 51–54, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Floris-Moore, A. A. Howard, Y. Lo, E. E. Schoenbaum, J. H. Arnsten, and R. S. Klein, “Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men,” AIDS Patient Care and STDs, vol. 21, no. 7, pp. 479–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Skowroński, D. Zozulińska-Ziółkiewicz, J. Juszczyk, W. Michalski, and B. Wierusz-Wysocka, “C-reactive protein and chronic hepatitis C virus infection in diabetic patients,” Polskie Archiwum Medycyny Wewnetrznej, vol. 120, no. 12, pp. 491–496, 2010. View at Google Scholar
  13. C. F. Huang, M. Y. Hsieh, J. F. Yang et al., “Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients,” Hepatology International, vol. 4, no. 3, pp. 621–627, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Clerico and M. Emdin, “Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides:a review,” Clinical Chemistry, vol. 50, no. 1, pp. 33–50, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Bassan, A. Potsch, A. Maisel et al., “B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation,” European Heart Journal, vol. 26, no. 3, pp. 234–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. S. Sabatine, D. A. Morrow, J. A. De Lemos et al., “Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia,” Journal of the American College of Cardiology, vol. 44, no. 10, pp. 1988–1995, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. J. Wang, M. G. Larson, D. Levy et al., “Plasma natriuretic peptide levels and the risk of cardiovascular events and death,” New England Journal of Medicine, vol. 350, no. 7, pp. 655–663, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Matsumori, T. Shimada, N. M. Chapman, S. M. Tracy, and J. W. Mason, “Myocarditis and heart failure associated with hepatitis C virus infection,” Journal of Cardiac Failure, vol. 12, no. 4, pp. 293–298, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Antonelli, C. Ferri, S. M. Ferrari et al., “High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C,” Journal of Viral Hepatitis, vol. 17, no. 12, pp. 851–853, 2010. View at Publisher · View at Google Scholar · View at Scopus